CD274 and cancer: The PD-1 receptor, which is found on the surface of T cells, upon engagement by its ligand PD-L1—often overexpressed on cancer cells—recruits SHP2 phosphatases via ITSM motifs, leading to the inhibition of TCR signaling and inhibition of cytokine secretion and effector lymphocyte proliferation.